Back

REVEAL-CKD: Prevalence of undiagnosed stage 3 chronic kidney disease in patients with heart failure in Canada

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - comorbidities Comorbidities HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Krister Jarbrink

BioPharmaceuticals Medical, AstraZeneca, Gothenburg (Sweden)

7 More presentations in this session

Presentation thumbnail
Impact of anemia on long-term clinical outcome in patients with mildly reduced left ventricular systolic function after acute myocardial infarction
Doctor J. Seung (Seoul, KR)
Abstract Slides
Presentation thumbnail
Cardio-renal-metabolic syndrome in a cohort of patients with chronic heart failure: prevalence and prognosis. An analysis of OFFICE IC AR Registry
Doctor J. Thierer (Buenos Aires, AR)
Abstract Slides
Presentation thumbnail
The patter of muscle mass wasting in elder patients with heart failure is associated with mortality: a post-hoc analysis of the FRAGILE-HF
Mr T. Sunayama (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Soluble transferrin receptor as a marker of tissue iron deficiency: impact on cardiac, systemic, hematinic and neurohormonal biomarkers in patients with heart failure without systemic iron deficiency
Doctor R. Ramos Polo (Hospitalet De Llobregat, ES)
Abstract Slides
Presentation thumbnail
Low levels of selenoprotein P associate with cognitive impairment in patients with acute heart failure
Doctor A. Jujic (Malmo, SE)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure - comorbidities

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023
You may be interested in
thumbnail
Congress Presentation
Therapeutic implications of the cardio-renal-metabolic multimorbidity
thumbnail
Congress Presentation
Prognostic implications of multimorbidity in patients with heart failure with mildly reduced ejection fraction
thumbnail
Congress Presentation
Obesity and inactivity cluster is the strongest predictor of incident heart failure in a population-based study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources